Sumit Aggarwal
CIK: 0001854362
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eloxx Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 10, 2026ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
328.8K shares- - Feb 28, 2026ELOX
Eloxx Pharmaceuticals, Inc.
Exercise(M)Direct260.9K shares at avg. $0.15$39K - Jan 24, 2026ELOX
Eloxx Pharmaceuticals, Inc.
Exercise(M)Direct15K shares- - Sep 19, 2025ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)Direct1M shares- - Aug 14, 2025ELOX
Eloxx Pharmaceuticals, Inc.
Exercise(M)Direct196.9K shares at avg. $0.00$19.688 - Jan 24, 2025ELOX
Eloxx Pharmaceuticals, Inc.
Exercise(M)Direct30K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Disposition(D)DirectStock Option (Right to Buy)
42.8K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
42.8K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Disposition(D)DirectStock Option (Right to Buy)
35.6K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
35.6K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Disposition(D)DirectStock Option (Right to Buy)
68.7K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
68.7K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Disposition(D)DirectStock Option (Right to Buy)
24.8K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
24.8K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)Direct165K shares- - Feb 6, 2022ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
42.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 328,833 | - | - | Direct |
| Feb 28, 2026 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise(M) | 260,946 | $0.15 | $39,142 | Direct |
| Jan 24, 2026 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise(M) | 15,000 | - | $0 | Direct |
| Sep 19, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) | 1,000,000 | - | $0 | Direct |
| Aug 14, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise(M) | 196,880 | $0.00 | $20 | Direct |
| Jan 24, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise(M) | 30,000 | - | $0 | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Disposition(D) Stock Option (Right to Buy) | 42,790 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 42,790 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Disposition(D) Stock Option (Right to Buy) | 35,580 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 35,580 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Disposition(D) Stock Option (Right to Buy) | 68,700 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 68,700 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Disposition(D) Stock Option (Right to Buy) | 24,810 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 24,810 | - | - | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) | 165,000 | - | $0 | Direct |
| Feb 6, 2022 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 42,790 | - | - | Direct |
1-16 of 16 transactions
About Aggarwal Sumit
Aggarwal Sumit (SEC CIK 0001854362) files insider reports with the SEC as President and CEO of Eloxx Pharmaceuticals, Inc. (ELOX).
Signal8 holds 4 ownership filings by Aggarwal Sumit, all Form 4s, filed between Oct 17, 2024 and Jun 10, 2026. Those filings report 16 transactions, from Feb 6, 2022 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aggarwal Sumit's filings is in ARLINGTON, MA.
Recent filings by Aggarwal Sumit
- Jun 10, 2026: Grant or award of ELOX derivative securities (Form 4, code A).
- Feb 28, 2026: Option exercise of ELOX shares (Form 4, code M).
- Jan 24, 2026: Option exercise of ELOX shares (Form 4, code M).
- Sep 19, 2025: Grant or award of ELOX shares (Form 4, code A).
- Aug 14, 2025: Option exercise of ELOX shares (Form 4, code M).
Other insiders filing for Eloxx Pharmaceuticals, Inc. (ELOX)
- Germano Geno J, Director
- Domicilium Real Estate Fund III LP, 10% Owner
- Webster Stephen W, Director
- Walts Alan Edmund, Director
- Kjellson Nina S, Director
- Rubin Steven D, Director